Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)

por Li, Fei, Tang, Shou-Ching
Publicado 2017

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions

por Wynn, Carrie S., Tang, Shou-Ching
Publicado 2022

The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options

por Wang, Yating, Tang, Shou-Ching
Publicado 2022

First Report of Parkinsonism Associated With Indoximod, an Immune-Modulating Agent

por Floyd, Mark, El Osta, Badi, Tang, Shou-Ching
Publicado 2016

Synchronous papillary thyroid carcinoma and breast ductal carcinoma

por Kong, Heng, Chen, JiXin, Tang, Shou-Ching
Publicado 2020

Unfortunate Accident or Blessing in Disguise? Dramatic Response to Incidental Intrathoracic Delivery of Anti-HER2 Regimen

por Tariq, Khurram, Keen, Ryan, Draper, Karen, Tang, Shou-Ching
Publicado 2017

Metastatic Breast Cancer Presenting As Orbital Mass: A Case Report With Literature Review

por Shaikh, Rizwan, Tariq, Khurram, Sharma, Suash, Tang, Shou-Ching
Publicado 2017

Highlights of the 2015 San Antonio Breast Cancer Symposium

por Keaton, Mark, Tripathy, Debu, O'Shaughnessy, Joyce, Tang, Shou-Ching
Publicado 2016

Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity

por Sadek, Ibrahim, Keaton, Mark, Maihle, Nita J., Tang, Shou-Ching
Publicado 2017

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency

por Sun, Xin, Liu, Jian, Xu, Chongwen, Tang, Shou‐Ching, Ren, Hong
Publicado 2016

The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer

por Rimando, Joseph, Campbell, Jeff, Kim, Jae Hee, Tang, Shou-Ching, Kim, Sangmi
Publicado 2016

Bifocal juvenile papillomatosis as a marker of breast cancer: A case report and review of the literature

por WANG, TONG, LI, YA-QING, LIU, HONG, FU, XI-LIN, TANG, SHOU-CHING
Publicado 2014

Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth

por Xue, Lu, Maihle, Nita J., Yu, Xiaolin, Tang, Shou-Ching, Liu, Hong Yan
Publicado 2018

Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

por Li, Kai, Ma, Lei, Sun, Ye, Li, Xiang, Ren, Hong, Tang, Shou-Ching, Sun, Xin
Publicado 2023

The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

por Li, Kai, Ma, Lei, Sun, Ye, Li, Xiang, Ren, Hong, Tang, Shou-Ching, Sun, Xin
Publicado 2021

Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1

por Xie, Xiayang, Tang, Shou-Ching, Cai, Yafei, Pi, Wenhu, Deng, Libin, Wu, Guangyu, Chavanieu, Alain, Teng, Yong
Publicado 2016

Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells

por Negrón-Vega, Lisandra, Cora, Elsa M., Pérez-Torres, Marianela, Tang, Shou-Ching, Maihle, Nita J., Ryu, Jung Su
Publicado 2022

LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway: LINC00891 impedes lung cancer progression

por Zhang, Yunfeng, Song, Dingli, Peng, Ziyang, Wang, Rui, Li, Kai, Ren, Hong, Sun, Xin, Du, Ning, Tang, Shou-Ching
Publicado 2022

Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarc...

por Zhao, Qingchun, Xu, Song, Liu, Jinghao, Li, Ying, Fan, Yaguang, Shi, Tao, Wei, Sen, Tang, Shou-Ching, Liu, Hongyu, Chen, Jun
Publicado 2015

Augmented expression of polo-like kinase 1 indicates poor clinical outcome for breast patients: a systematic review and meta-analysis

por Zhang, Yunfeng, Wu, Zhibin, Liu, Dapeng, Wang, Meng, Xiao, Guodong, Wang, Peili, Sun, Xin, Ren, Hong, Tang, Shou-Ching, Du, Ning
Publicado 2017